Sumitomo Pharma (DNPUF) Short Interest Ratio & Short Volume $6.53 0.00 (0.00%) As of 06/20/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Sumitomo Pharma Short Interest DataSumitomo Pharma (DNPUF) has a short interest of 7.05 million shares. This marks a -0.97% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 461 shares to cover all short positions.Current Short Interest7,046,400 sharesPrevious Short Interest7,115,300 sharesChange Vs. Previous Month-0.97%Dollar Volume Sold Short$46.01 millionShort Interest Ratio0.0 Days to CoverLast Record DateMay 31, 2025Today's Trading Volume0 sharesAverage Trading Volume461 sharesToday's Volume Vs. Average0% Short Selling Sumitomo Pharma? Sign up to receive the latest short interest report for Sumitomo Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDNPUF Short Interest Over TimeDNPUF Days to Cover Over TimeDNPUF Percentage of Float Shorted Over Time Sumitomo Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20257,046,400 shares $46.01 million -1.0%N/A0 $6.53 5/15/20257,115,300 shares $46.46 million -3.8%N/A71153 $6.53 4/30/20257,399,700 shares $30.34 million +3.5%N/A0 $4.10 4/15/20257,150,700 shares $28.60 million +7.9%N/A71507 $4.00 3/31/20256,627,600 shares $31.52 million +1.1%N/A66276 $4.76 3/15/20256,558,000 shares $29.51 million +0.4%N/A16395 $4.50 2/28/20256,531,100 shares $32.66 million -1.5%N/A21770.3 $5.00 2/15/20256,627,600 shares $34.46 million +124.8%N/A66276 $5.20 1/31/20252,948,700 shares $11.79 million -2.7%N/A29487 $4.00 1/15/20253,029,300 shares $12.12 million +7.5%N/A10097.7 $4.00 Get the Latest News and Ratings for DNPUF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sumitomo Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/20242,818,000 shares $11.64 million -8.9%N/A0 $4.13 12/15/20243,093,100 shares $12.77 million -11.6%N/A814 $4.13 11/30/20243,497,400 shares $13.29 million +4.8%N/A34974 $3.80 11/15/20243,337,300 shares $12.68 million -25.1%N/A1963.1 $3.80 10/31/20244,452,800 shares $19.15 million -3.9%N/A44528 $4.30 10/15/20244,632,500 shares $19.92 million +39.8%N/A842.3 $4.30 9/30/20243,313,100 shares $13.42 million -0.4%N/A33131 $4.05 9/15/20243,324,700 shares $14.96 million +5.6%N/A0 $4.50 8/31/20243,149,100 shares $14.17 million -67.4%N/A31491 $4.50 8/15/20249,669,900 shares $27.85 million -1.2%N/A0 $2.88 7/31/20249,786,500 shares $28.19 million +4.0%N/A97865 $2.88 7/15/20249,408,700 shares $22.77 million -1.1%N/A4480.3 $2.42 6/30/20249,515,300 shares $18.94 million +7.2%N/A95153 $1.99 6/15/20248,879,700 shares $20.07 million -20.3%N/A4933.2 $2.26 5/31/202411,135,000 shares $25.17 million +3.3%N/A37116.7 $2.26 5/15/202410,780,900 shares $28.19 million -0.8%N/A1211.3 $2.62 4/30/202410,864,900 shares $29.34 million -0.1%N/A5718.4 $2.70 4/15/202410,876,900 shares $26.10 million +8.1%N/A0 $2.40 3/31/202410,057,800 shares $24.14 million -3.1%N/A100578 $2.40 3/15/202410,380,800 shares $24.91 million +2.4%N/A103808 $2.40 2/29/202410,140,000 shares $23.93 million +5.3%N/A2304.5 $2.36 2/15/20249,626,700 shares $21.85 million +14.4%N/A2750.5 $2.27 1/15/20247,551,500 shares $23.64 million +24.4%N/A1238 $3.13 12/31/20236,070,500 shares $19.00 million +3.6%N/A1407.5 $3.13 12/15/20235,857,100 shares $18.27 million +10.1%N/A29285.5 $3.12 11/30/20235,320,400 shares $16.97 million +11.7%N/A1716.3 $3.19 11/15/20234,763,100 shares $14.22 million -1.0%N/A1642.4 $2.99 10/31/20234,813,400 shares $14.30 million -0.1%N/A2187.9 $2.97 10/15/20234,819,000 shares $16.87 million -4.2%N/A845.4 $3.50 9/30/20235,031,100 shares $18.29 million -9.2%N/A50311 $3.64Trump’s true trade war strategy (Ad)The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.This is fast becoming the world’s most sought-after resource. 9/15/20235,538,000 shares $19.88 million +14.4%N/A1065 $3.59 8/31/20234,842,500 shares $18.00 million -1.3%N/A969.3 $3.72 8/15/20234,903,900 shares $21.43 million +44.5%N/A0 $4.37 7/31/20233,394,100 shares $14.83 million -2.3%N/A0 $4.37 7/15/20233,472,900 shares $15.18 million +7.2%N/A0 $4.37 6/30/20233,239,700 shares $14.16 million +3.3%N/A1117.1 $4.37 6/15/20233,136,700 shares $16.25 million +34.2%N/A15683.5 $5.18 5/31/20232,337,100 shares $12.11 million +37.3%N/A1230.1 $5.18 5/15/20231,702,000 shares $10.03 million +6.6%N/A17020 $5.90 4/30/20231,596,600 shares $9.72 million +4.0%N/A939.2 $6.09 4/15/20231,535,900 shares $9.71 million +5.5%N/A7679.5 $6.33 3/31/20231,455,600 shares $9.28 million +0.4%N/A4852 $6.38 3/15/20231,449,400 shares $9.24 million +19.7%N/A14494 $6.38 2/28/20231,211,400 shares $7.72 million -7.6%N/A6057 $6.38 2/15/20231,311,500 shares $8.45 million +4.1%N/A13115 $6.44 1/31/20231,260,500 shares $9.33 million -5.0%N/A12605 $7.40 1/15/20231,326,400 shares $9.82 million +10.5%N/A13264 $7.40 12/30/20221,199,900 shares $8.88 million -3.4%N/A11999 $7.40 12/15/20221,241,500 shares $9.44 million +16.7%N/A4138.3 $7.60 11/30/20221,063,700 shares $7.88 million -3.9%N/A3545.7 $7.41 11/15/20221,106,900 shares $7.63 million -2.0%N/A11069 $6.89 10/31/20221,128,900 shares $7.78 million -3.7%N/A1026.3 $6.89 10/15/20221,172,800 shares $8.09 million +27.7%N/A325.8 $6.90 9/30/2022918,100 shares $7.53 million -12.4%N/A9181 $8.20 9/15/20221,048,500 shares $8.60 million +2.6%N/A10485 $8.20 8/31/20221,021,600 shares $8.38 million -1.3%N/A10216 $8.20 8/15/20221,034,500 shares $8.48 million +7.2%N/A10345 $8.20 7/31/2022965,400 shares $7.43 million +14.0%N/A1379.1 $7.70 7/15/2022846,700 shares $6.52 million +1.4%N/A8467 $7.70 6/30/2022834,800 shares $6.44 million -10.5%N/A194.1 $7.72 6/15/2022933,100 shares $8.09 million -26.3%N/A1036.8 $8.67 5/31/20221,266,200 shares $12.27 million +15.2%N/A2532.4 $9.69 5/15/20221,099,600 shares $10.66 million -19.8%N/A687.3 $9.69 4/30/20221,370,900 shares $11.76 million +41.0%N/A13709 $8.58 4/15/2022972,100 shares $9.93 million +9.7%N/A405 $10.22 3/31/2022886,000 shares $9.05 million +4.1%N/A8860 $10.22 3/15/2022851,300 shares $8.99 million +11.7%N/A851.3 $10.56 2/28/2022762,300 shares $8.05 million -4.2%N/A7623 $10.56 2/15/2022795,700 shares $8.40 million +6.5%N/A1989.3 $10.56 1/31/2022747,100 shares $7.67 million +6.7%N/A324.8 $10.27 1/15/2022700,000 shares $8.47 million +12.2%N/A1750 $12.10 12/31/2021623,700 shares $7.65 million +7.2%N/A6237 $12.26 12/15/2021582,100 shares $6.99 million +26.5%N/A5821 $12.00 11/30/2021460,300 shares $6.28 million +28.8%N/A4603 $13.64 11/15/2021357,300 shares $4.87 million -22.7%N/A3573 $13.64 10/29/2021462,200 shares $7.73 million +38.3%N/A256.8 $16.72 10/15/2021334,300 shares $5.82 million -19.8%N/A3343 $17.40 9/30/2021416,900 shares $6.86 million +10.0%N/A83.4 $16.45 9/15/2021379,100 shares $6.24 million +34.9%N/A189.6 $16.45 8/31/2021281,000 shares $4.62 million -37.3%N/A0 $16.45Gold is soaring. Here’s how to get paid from it (Ad)Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.Click here to discover the income ETF behind it all. 8/13/2021448,100 shares $7.37 million -3.9%N/A2240.5 $16.45 7/30/2021466,300 shares $9.42 million -4.7%N/A4663 $20.20 7/15/2021489,100 shares $9.88 million -5.6%N/A4891 $20.20 6/30/2021517,900 shares $10.23 million -26.9%N/A0 $19.75 6/15/2021708,100 shares $13.98 million +26.0%N/A1180.2 $19.75 5/28/2021562,000 shares $9.78 million -2.9%N/A5620 $17.40 5/14/2021578,600 shares $10.07 million -13.6%N/A5786 $17.40 4/30/2021669,500 shares $11.65 million +0.7%N/A0 $17.40 4/15/2021664,800 shares $11.57 million -5.9%N/A6648 $17.40 3/31/2021706,800 shares $13.25 million -13.3%N/A46.8 $18.75 3/15/2021815,100 shares $13.45 million -59.3%N/A2717 $16.50 2/26/20212,002,300 shares $33.04 million -3.5%N/A10011.5 $16.50 2/12/20212,075,400 shares $31.13 million +1.7%N/A0 $15.00 1/29/20212,041,300 shares $30.11 million -8.2%N/A20413 $14.75 1/15/20212,030,100 shares $29.94 million +2.1%N/A76.9 $14.75 12/31/20202,080,400 shares $26.63 million +2.5%N/A20804 $12.80 12/15/20202,030,100 shares $25.99 million +2.1%N/A76.9 $12.80 11/30/20201,988,900 shares $25.86 million +17.7%N/A19889 $13.00 11/15/20201,690,500 shares $22.48 million +4.4%N/A2817.5 $13.30 10/30/20201,619,000 shares $20.97 million -1.4%N/A2698.3 $12.95 10/15/20201,641,700 shares $21.26 million +4.4%N/A5472.3 $12.95 9/30/20201,572,700 shares $21.31 million +8.1%N/A7863.5 $13.55 9/15/20201,455,400 shares $18.56 million -0.1%N/A2910.8 $12.75 8/31/20201,456,800 shares $21.12 million -0.4%N/A0 $14.50 8/14/20201,462,900 shares $19.90 million +34.3%N/A7314.5 $13.60 7/31/20201,089,000 shares $13.61 million +3.2%N/A198 $12.50 7/15/20201,055,400 shares $13.93 million -0.2%N/A10554 $13.20 6/30/20201,057,300 shares $15.07 million -5.4%N/A10573 $14.25 DNPUF Short Interest - Frequently Asked Questions What is Sumitomo Pharma's current short interest? Short interest is the volume of Sumitomo Pharma shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 7,046,400 shares of DNPUF short. Learn More on Sumitomo Pharma's current short interest. Is Sumitomo Pharma's short interest increasing or decreasing? Sumitomo Pharma saw a decline in short interest in the month of May. As of May 31st, there was short interest totaling 7,046,400 shares, a decline of 1.0% from the previous total of 7,115,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Sumitomo Pharma stock? Short selling DNPUF is an investing strategy that aims to generate trading profit from Sumitomo Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sumitomo Pharma? A short squeeze for Sumitomo Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DNPUF, which in turn drives the price of the stock up even further. How often is Sumitomo Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DNPUF, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies 1933 Industries Short Interest Data 4Cable TV International Short Interest Data 4Front Ventures Short Interest Data AB Science Short Interest Data Aleafia Health Short Interest Data Almirall Short Interest Data Alvotech Short Interest Data American Green Short Interest Data Avant Brands Short Interest Data Avicanna Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:DNPUF) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sumitomo Pharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sumitomo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DNPUF Stock Free DNPUF Stock Alerts